Lack of a clinically relevant interaction between etanercept (E) & digoxin (D).

被引：0
|
作者：
Patat, AA
Parks, V
Simcoe, DK
Korth-Bradley, JM
Le Coz, F
机构：
[1] Wyeth Ayerst Res, Paris, France
[2] Wyeth Ayerst Res, Collegeville, PA USA
[3] Biotrial, Rennes, France
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2002年 / 71卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P64 / P64
页数：1
相关论文
共 50 条
  • [1] Absence of a clinically relevant interaction between etanercept and digoxin
    Zhou, HH
    Parks, V
    Patat, A
    Le Coz, F
    Simcoe, D
    Korth-Bradley, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (11): : 1244 - 1251
  • [2] Lack of clinically relevant interaction between desloratadine and erythromycin
    Banfield, C
    Hunt, T
    Reyderman, L
    Statkevich, P
    Padhi, D
    Affrime, M
    CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 1) : 29 - 35
  • [3] Lack of Clinically Relevant Interaction Between Desloratadine and Erythromycin
    Christopher Banfield
    Thomas Hunt
    Larisa Reyderman
    Paul Statkevich
    Desmond Padhi
    Melton Affrime
    Clinical Pharmacokinetics, 2002, 41 : 29 - 35
  • [4] IS THERE A CLINICALLY RELEVANT INTERACTION BETWEEN QUININE AND DIGOXIN IN HUMAN-BEINGS - REPLY
    WILKERSON, RD
    AMERICAN JOURNAL OF CARDIOLOGY, 1981, 48 (05): : 975 - 976
  • [5] Lack of clinically relevant pharmacokinetic interaction between bazedoxifene and ibubrofen.
    Baird, SJ
    McKeand, WE
    Ermer, JC
    Patat, AA
    Garcia-Quetglas, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P94 - P94
  • [6] CLINICALLY SIGNIFICANT INTERACTION BETWEEN DIGOXIN AND QUINIDINE
    HOLT, DW
    HAYLER, AM
    EDMONDS, ME
    ASHFORD, RF
    BRITISH MEDICAL JOURNAL, 1979, 2 (6202): : 1401 - 1401
  • [7] Lack of clinically significant interaction between steady state tolvaptan and digoxin in healthy volunteers.
    Shoaf, SE
    Wang, Z
    Mallikaarjun, S
    Bricmont, P
    Bramer, SL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P37 - P37
  • [8] Lack of kinetic interaction between digoxin and voglibose
    Kusumoto, M
    Ueno, K
    Fujimura, Y
    Kameda, T
    Mashimo, K
    Takeda, K
    Tatami, R
    Shibakawa, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (01) : 79 - 80
  • [9] Lack of kinetic interaction between digoxin and voglibose
    M. Kusumoto
    K. Ueno
    Y. Fujimura
    T. Kameda
    K. Mashimo
    K. Takeda
    R. Tatami
    M. Shibakawa
    European Journal of Clinical Pharmacology, 1999, 55 : 79 - 80
  • [10] Lack of Clinically Relevant Drug-Drug Interaction Between Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, and Verapamil, Ramipril, or Digoxin in Healthy Volunteers
    Macha, Sreeraj
    Sennewald, Regina
    Rose, Peter
    Schoene, Katja
    Pinnetti, Sabine
    Woerle, Hans J.
    Broedl, Uli C.
    CLINICAL THERAPEUTICS, 2013, 35 (03) : 226 - 235
12345